Model for End-Stage Liver Disease (MELD) exception for severe pruritus

Liver Transplantation

Volumn 12, Issue 12 SUPPL. 3, 2006, Pages

  Washburn, W Kenneth ^a   Gish, Robert G ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLESTYRAMINE; NALOXONE; ONDANSETRON; PHENOBARBITAL; RIFAMPICIN; TROPISETRON; URSODEOXYCHOLIC ACID;

ALBUMIN DIALYSIS; ARTICLE; CHOLESTASIS; DISEASE SEVERITY; HEMODIALYSIS; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; PATIENT SELECTION; PLASMAPHERESIS; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; SUICIDAL IDEATION;

HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MODELS, BIOLOGICAL; PRURITUS; SEVERITY OF ILLNESS INDEX; TISSUE AND ORGAN PROCUREMENT;

EID: 33845488944     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20976     Document Type: Article

References (5)

1. Neuberger J. Liver transplantation for cholestatic liver disease. Curr Treat Options Gastroenterol 2003;6:113-121.
2. Bellmann R, Graziadei IW, Feistritzer C, Schwaighofer H, Stellaard F, Sturm E, et al. Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis. Liver Transpl 2004; 10: 107-114.
3. Bellmann R, Feistritzer C, Zoller H, Graziadei IW, Schwaighofer H, Propst A, et al. Treatment of intractable pruritus in drug induced cholestasis with albumin dialysis: a report of two cases. ASAIO J 2004; 50:387-391.
4. Bergasa NV. Pruritus in chronic liver disease: mechanisms and treatment. Curr Gastroenterol Rep 2004;6:10-16.
5. Younossi ZM, Kiwi ML, Boparai N, Price LL, Guyatt G. Cholestatic liver diseases and health-related quality of life. Am J Gastroenterol 2000;95:497-502.